instruction stringlengths 1.03k 1.87k | output stringlengths 554 1.04k |
|---|---|
SUBJECT: Adverse reaction report involving Product A and Product B completed course before reaction
Good morning,
I am the Clinical Pharmacy Director at a home healthcare nursing agency and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adve... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Safety report Product A and Product B unchanged during reaction
Dear Pharmacovigilance and Risk Management Team,
I am the Clinical Pharmacy Director at an immunology and allergy clinic and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Adverse event notification for Product A with suspect Product B also implicated
Dear Corporate Drug Safety Department,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating phy... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Pharmacovigilance report Product A with suspect Product B also implicated
Dear Post-Marketing Surveillance Unit,
I am the Head of Pharmacy Services at a pharmaceutical benefit manager and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Formal adverse event notification Product A with dual drug reaction Product A and Levothyroxine
To Whom It May Concern,
I am writing as the caregiver for my husband Lisa Castillo to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where t... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Adverse event report Product A plus concomitant Product B exposure
Dear Patient Safety Team,
I am the Senior Nurse Practitioner at a rheumatology clinic group and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient experienced a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Product A adverse reaction with suspect Product B also implicated
Dear Corporate Drug Safety Department,
I am the Consultant Endocrinologist at an integrated care system and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the t... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A reaction report with suspected combined effect Product A and Amlodipine
Dear Pharmacovigilance Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medicati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Product A reaction and concomitant Ibuprofen therapy formal notification
Hi,
I am the Chief of Medicine at a chain of retail pharmacies and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient experienced a 60 year old male p... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Adverse event report Product A plus previous Product B therapy
Dear Pharmacovigilance Team,
I am the Attending Physician at a dialysis centre network and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient experienced a 59 y... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Adverse reaction report involving Product A and suspect Product B also implicated
Dear Sir or Madam,
I am the Consultant Rheumatologist at an integrated care system and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the treati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Adverse event report Product A plus previous Product B therapy
Dear Adverse Events Reporting Centre,
I am the Clinical Pharmacist at a private cardiology practice group and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse even... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Product A reaction and Levothyroxine maintained as background medication formal notification
Dear Patient Safety Team,
I am the Consultant Gastroenterologist at a dialysis centre network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Adverse reaction report involving Product A and concurrent Product B use
Dear Clinical Safety and Regulatory Affairs,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 53 year old female patie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Suspected adverse event with Product A and ongoing Ibuprofen use alongside Product A
Dear Pharmacovigilance Team,
I am writing as the caregiver for my sister Karen Owens to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experience... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Adverse reaction report involving Product A and suspect Product A with suspect Methotrexate
Dear Sir or Madam,
I am the Clinical Pharmacy Director at a large academic medical centre and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Product A reaction report with both Product A and Amoxicillin identified as suspect
Dear Patient Safety Team,
I am the Clinical Nurse Specialist at an immunology and allergy clinic and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a serious adverse eve... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Product A adverse event and Amoxicillin excluded as causative agent report
Dear Regional Pharmacovigilance Lead,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 55 year ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Product A suspected adverse reaction with Atorvastatin also suspected by physician
Dear Sir or Madam,
I am the Consultant Haematologist at a specialist dermatology centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Serious adverse event report Product A and continued Product B administration
Dear Clinical Safety and Regulatory Affairs,
I am the Pharmacy Operations Manager at a rheumatology clinic group and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Suspected adverse event with Product A and Levothyroxine not implicated in adverse event
To Whom It May Concern,
I am the Head of Pharmacy Services at a multi-site primary care network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Serious adverse event report Product A and suspect Product B also implicated
Hi,
I am the Consultant Gastroenterologist at an immunology and allergy clinic and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the treating physic... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Serious adverse event report Product A and Product B stopped before symptoms began
Dear Post-Marketing Surveillance Unit,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 59 year old male pat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Adverse reaction report involving Product A and Product B historical exposure documented
Dear Global Safety Unit,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 58 year old male patient on ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Product A adverse event and Product B concomitant medication report
Dear Drug Safety Department,
I am the Medical Director at a rehabilitation and long-term care facility and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Suspected adverse event with Product A and Product B completed course before reaction
Dear Drug Safety Department,
I am the Senior Consultant at a childrens hospital outpatient department and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event.... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Product A adverse event and dual drug reaction Product A and Methotrexate report
Dear Medical Affairs and Drug Safety,
I am the Consultant Rheumatologist at a cancer centre network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Product A reaction report with suspect Product B also implicated
Dear Regional Pharmacovigilance Lead,
I am the Clinical Nurse Specialist at a gastroenterology clinic partnership and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a serious adverse event... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Product A adverse event and concurrent Product B use report
To Whom It May Concern,
I am writing as the caregiver for my husband Adam Green to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 45 year old female patient... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Formal adverse event notification Product A with Product B unchanged during reaction
Dear Regional Pharmacovigilance Lead,
I am writing as the caregiver for my sister Cynthia Mills to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Formal adverse event notification Product A with past Product B exposure
Dear Post-Marketing Surveillance Unit,
I am the Ward Nurse Manager at a clinical research site network and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Adverse reaction report involving Product A and Product B discontinued prior to event
Dear Sir or Madam,
I am the Clinical Pharmacy Director at a community health partnership covering 12 clinics and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Product A adverse reaction with Product B taken alongside
Dear Patient Safety Team,
I am the Consultant Endocrinologist at a pharmaceutical benefit manager and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 41 ye... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Safety report Product A and past Product B exposure
Dear Pharmacovigilance Team,
I am writing as the caregiver for my wife Brandon Hunter to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 53 year old female patient s... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Product A adverse reaction with Product B prior use not relevant
Dear Corporate Drug Safety Department,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 62 year old male ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Product A suspected adverse reaction with Product B as background therapy
To Whom It May Concern,
I am writing as the caregiver for my elderly aunt Sharon Jenkins to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 34 ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Product A adverse reaction with suspect Product B also implicated
Dear Global Safety Unit,
I am the Director of Clinical Services at a pharmaceutical benefit manager and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse event where th... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Product A suspected adverse reaction with suspect Product B also implicated
Dear Regional Pharmacovigilance Lead,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physicia... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Suspected adverse event with Product A and suspect Product B also implicated
Dear Global Safety Unit,
I am the Consultant Endocrinologist at a mental health trust and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the treating... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Adverse reaction report involving Product A and Ibuprofen continued without change
Good morning,
I am the Consultant Nephrologist at a paediatric outpatient service and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experience... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Adverse reaction report involving Product A and Methotrexate also suspected by physician
To Whom It May Concern,
I am the Consultant Pulmonologist at a Veterans Affairs medical centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse eve... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Adverse reaction report involving Product A and Product B unchanged during reaction
Dear Medical Affairs and Drug Safety,
I am the Senior Nurse Practitioner at a childrens hospital outpatient department and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Product A reaction and suspected combined effect Product A and Amoxicillin formal notification
Dear Corporate Drug Safety Department,
I am the Medical Director at a community health partnership covering 12 clinics and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Serious adverse event report Product A and suspect Product B also implicated
Dear Regional Pharmacovigilance Lead,
I am the Consultant Endocrinologist at a private cardiology practice group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adver... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Safety report Product A and previous Product B therapy
Dear Global Safety Unit,
I am the Clinical Nurse Specialist at a Veterans Affairs medical centre and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient experienced a 48 yea... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Adverse reaction report involving Product A and Lisinopril not implicated in adverse event
To Whom It May Concern,
I am writing as the caregiver for my sister Christine Elliott to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient exp... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Adverse event notification for Product A with Atorvastatin taken concurrently not suspected
Dear Global Safety Unit,
I am the Medical Director at a rehabilitation and long-term care facility and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adve... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Product A reaction and concurrent Product B use formal notification
Dear Pharmacovigilance and Risk Management Team,
I am writing as the caregiver for my elderly aunt Justin Ferguson to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Product A suspected reaction with suspect Product B also implicated – formal report
Dear Patient Safety Team,
I am the Consultant Pulmonologist at a womens health clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Adverse event notification for Product A with suspect Product B also implicated
Hi,
I am the Consultant Rheumatologist at a surgical day case unit group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the treating physician... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Suspected adverse event with Product A and concomitant Metformin therapy
Hi,
I am the Clinical Pharmacist at a womens health clinic group and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The patient experienced a 53... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Product A adverse event and concomitant Lisinopril therapy report
Dear Adverse Events Reporting Centre,
I am the Consultant Endocrinologist at a private cardiology practice group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Pharmacovigilance report Product A with dual drug reaction Product A and Atorvastatin
To Whom It May Concern,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medicatio... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Product A suspected reaction with Product B not suspected – formal report
Dear Patient Safety Team,
I am the Medical Director at a large academic medical centre and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient experie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Product A suspected adverse reaction with both Product A and Methotrexate identified as suspect
Dear Global Safety Unit,
I am the Consultant Nephrologist at a managed care organisation and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse ev... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Adverse reaction report involving Product A and Ibuprofen stable during Product A reaction
Dear Regional Pharmacovigilance Lead,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Product A reaction report with Levothyroxine not implicated in adverse event
Hi,
I am the Medical Director at a large endocrinology centre and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient experienced a 42 year old mal... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Formal adverse event notification Product A with concomitant Lisinopril therapy
Dear Post-Marketing Surveillance Unit,
I am the Pharmacy Operations Manager at a community health partnership covering 12 clinics and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy se... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Adverse event report Product A plus Product B as background therapy
Dear Corporate Drug Safety Department,
I am writing as the caregiver for my elderly aunt Jennifer Salazar to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Product A adverse event and past Product B exposure report
Dear Post-Marketing Surveillance Unit,
I am writing as the caregiver for my elderly aunt Kevin Cunningham to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 2... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A suspected adverse reaction with concurrent Product B use
Dear Drug Safety Department,
I am the Clinical Pharmacist at a specialist dermatology centre and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The pa... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Product A suspected adverse reaction with Metformin also suspected by physician
Hi,
I am the Director of Clinical Services at a managed care organisation and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse event where the treating p... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A reaction and suspected combined effect Product A and Metformin formal notification
Dear Pharmacovigilance Team,
I am the Clinical Pharmacy Director at a cancer centre network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Adverse reaction report involving Product A and concomitant Product B exposure
Dear Corporate Drug Safety Department,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 29 year old female patie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Urgent adverse event Product A and Lisinopril stable during Product A reaction
Dear Patient Safety Team,
I am the Consultant Neurologist at a regional hospital trust and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienc... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Formal adverse event notification Product A with Product B not currently administered
Dear Patient Safety Team,
I am the Consultant Pulmonologist at a mental health trust and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient expe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Product A adverse event and continued Product B administration report
Dear Pharmacovigilance and Risk Management Team,
I am the Ward Nurse Manager at a respiratory medicine centre and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A adverse reaction with Product B taken alongside
Dear Patient Safety Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 50 year old female patient on Product A for 15 weeks who d... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Product A suspected reaction with suspect Product B also implicated – formal report
Dear Post-Marketing Surveillance Unit,
I am writing as the caregiver for my husband Richard Ryan to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Serious adverse event report Product A and concurrent Product B use
Dear Pharmacovigilance and Risk Management Team,
I am the Consultant Gastroenterologist at a clinical research site network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse ev... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Product A adverse event and ongoing Product B treatment report
Dear Global Safety Unit,
I am the Medical Director at a gastroenterology clinic partnership and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient experienced a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Suspected adverse event with Product A and Product B stopped before symptoms began
Dear Global Safety Unit,
I am the Consultant Rheumatologist at a private cardiology practice group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The p... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Product A reaction and Product B stopped months ago formal notification
Dear Regional Pharmacovigilance Lead,
I am the Consultant Endocrinologist at a gastroenterology clinic partnership and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Adverse event notification for Product A with Product B historical medication only
Dear Medical Affairs and Drug Safety,
I am the Ward Nurse Manager at a multi-site primary care network and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Product A reaction and Product B not currently administered formal notification
Hi,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 48 year old female patient on Product... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Formal adverse event notification Product A with Product B historical medication only
Dear Global Safety Unit,
I am the Chief of Medicine at a womens health clinic group and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patien... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A adverse event and suspect Product A with suspect Omeprazole report
Dear Medical Affairs and Drug Safety,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Suspected adverse event with Product A and Product B historical medication only
Dear Medical Affairs and Drug Safety,
I am the Consultant Nephrologist at a pathology and diagnostics consortium and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse e... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Adverse reaction report involving Product A and physician suspects both Product A and Lisinopril
Dear Drug Safety Department,
I am the Consultant Rheumatologist at a mental health trust and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse e... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Urgent adverse event Product A and Product B not suspected
Dear Global Safety Unit,
I am writing as the caregiver for my mother Jonathan Martinez to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 58 year old male pat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Product A adverse event and Product B concomitant medication report
Dear Pharmacovigilance and Risk Management Team,
I am writing as the caregiver for my elderly aunt Jerry Harris to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Serious adverse event report Product A and Product A and Omeprazole jointly suspected
Dear Clinical Safety and Regulatory Affairs,
I am the Chief of Medicine at a pain management clinic group and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a seri... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Formal adverse event notification Product A with Product B excluded as cause
Dear Drug Safety Department,
I am the Clinical Pharmacy Director at a respiratory medicine centre and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an advers... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Product A reaction and suspect Product B also implicated formal notification
Dear Medical Affairs and Drug Safety,
I am the Consultant Haematologist at a womens health clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Urgent adverse event Product A and Product B completed course before reaction
Dear Patient Safety Team,
I am the Clinical Pharmacy Director at a wound care centre network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse ev... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Urgent adverse event Product A and suspected combined effect Product A and Amlodipine
Dear Clinical Safety and Regulatory Affairs,
I am the Consultant Gastroenterologist at a community health partnership covering 12 clinics and I am writing to formally report an adverse event involving a patient under my care.... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Adverse event notification for Product A with past Product B exposure
Dear Global Safety Unit,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 60 year old male patient o... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Product A reaction report with Product B stable throughout event
Dear Sir or Madam,
I am writing as the caregiver for my father Katherine Wilson to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 42 year old male pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Adverse event notification for Product A with Product A and Amoxicillin jointly suspected
Dear Drug Safety Department,
I am the Consultant Nephrologist at a university hospital department and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Safety report Product A and Product A and Metformin both implicated
To Whom It May Concern,
I am the Consultant Hepatologist at a large academic medical centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the treating ph... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Product A adverse reaction with suspected Omeprazole co-reaction
To Whom It May Concern,
I am writing as the caregiver for my wife Daniel Burns to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating physician suspects both... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Pharmacovigilance report Product A with dual drug reaction Product A and Ibuprofen
Dear Medical Affairs and Drug Safety,
I am the Clinical Pharmacist at an immunology and allergy clinic and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to repor... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Product A suspected adverse reaction with suspect Product B also implicated
Dear Patient Safety Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medications as co... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Suspected adverse event with Product A and Ibuprofen unchanged during event onset
Dear Regional Pharmacovigilance Lead,
I am the Head of Pharmacy Services at a residential care home network managing over 400 elderly residents across 5 facilities and I am submitting this adverse event report on behalf of a pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Product A suspected adverse reaction with Amoxicillin also suspected by physician
Hi,
I am writing as the caregiver for my father Nathan Lopez to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating physician suspects both ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Urgent adverse event Product A and ongoing Omeprazole use alongside Product A
Dear Regional Pharmacovigilance Lead,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 29 year old female patient... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Adverse reaction report involving Product A and concomitant Product B therapy
Dear Adverse Events Reporting Centre,
I am the Consultant Endocrinologist at a childrens hospital outpatient department and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adve... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Urgent adverse event Product A and Product A and Omeprazole both implicated
Dear Pharmacovigilance and Risk Management Team,
I am the Consultant Rheumatologist at a respiratory medicine centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious ad... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Adverse event notification for Product A with suspect Product B also implicated
Dear Adverse Events Reporting Centre,
I am the Head of Pharmacy Services at a clinical research site network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to re... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A adverse reaction with Lisinopril concomitant medication only
Hi,
I am the Consultant Haematologist at a regional hospital trust and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 60 year old male patien... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.